4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-006980
Director sold 27,750 shares at an average $11.07 ($307,259)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCANGOS GEORGE A Director | 2024-02-22 | Sale 10b5-1 | −10,028 | $10.05 | $100,737 | 130,711 | D |
| SCANGOS GEORGE A Director | 2024-02-26 | Sale 10b5-1 | −17,722 | $11.65 | $206,522 | 112,989 | D |
| Open-market sales · 27,750 sh · avg $11.07 · $307,259 | |||||||
Loading xslF345X05/wk-form4_1708993836.xml…